As of Apr 17
| -0.21 / -3.96%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +175.05% increase from the last price of 5.09.
The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.